Modulation of phorbol ester-induced contraction by endogenously released cyclooxygenase products in rat aorta

S. P. Williams, A. K. Campbell, N. Roszell, Leslie Myatt, G. D. Leikauf, R. M. Rapoport

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

This study tests the hypothesis that prostaglandins (PGs) released in response to phorbol esters act as modulators of the phorbol ester-induced smooth muscle contraction. The rate and magnitude of the phorbol 12-myristate 13-acetate (PMA)-induced contraction of deendothelialized rat aorta were decreased by the cyclooxygenase inhibitor, indomethacin. The thromboxane (Tx) A2/PGH2 receptor antagonist, SQ-29548, also inhibited PMA-induced contraction, and the magnitude of inhibition was greater than that due to indomethacin. PMA induced the release of PGI2, PGE2, PGF(2α), and arachidonic acid, but not TxA2. The amount of PGI2 released was greater than that of PGE2 and PGF(2α). Indomethacin blocked the PMA-induced release of PG, but not of arachidonic acid. In PMA-contracted tissues, PGF(2α), PGE2, and the stable PGI2 and PGH2 analogues, carbacyclin and U-46619, respectively, induced further contraction. Pretreatment of PMA-contracted tissues with SQ-29548 partially inhibited the PGF(2α)- and PGE2-induced contractions, completely inhibited contraction to U-46619, and reversed the carbacyclin-induced contraction to relaxation. These results demonstrate that, in rat aorta, PMA induces the release of PGs that exert both contractile and relaxant effects but whose net effect is to accelerate and augment the contraction induced by PMA. The PG-induced increase in PMA contraction is mediated, in large part, through TxA2/PGH2 receptor activation. The ability of various PGs, including carbacyclin, to activate the TxA2/PGH2 receptor suggests that one or more of these PGs, in addition to, presumably, PGH2, may be responsible for the increase in PMA contraction. PGI2 is the only endogenously released PG that can account for the relaxant effect.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume267
Issue number5 36-5
StatePublished - 1994
Externally publishedYes

Fingerprint

Phorbol Esters
prostaglandin synthase
Prostaglandin-Endoperoxide Synthases
aorta
Aorta
Acetates
esters
acetates
prostaglandins
Prostaglandins
Prostaglandin H2 Receptors Thromboxane A2
rats
Prostaglandins F
Epoprostenol
Dinoprostone
indomethacin
Indomethacin
Prostaglandin H2
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
arachidonic acid

Keywords

  • prostaglandin receptor
  • protein kinase C
  • smooth muscle
  • thromboxane receptor

ASJC Scopus subject areas

  • Physiology
  • Agricultural and Biological Sciences(all)

Cite this

Modulation of phorbol ester-induced contraction by endogenously released cyclooxygenase products in rat aorta. / Williams, S. P.; Campbell, A. K.; Roszell, N.; Myatt, Leslie; Leikauf, G. D.; Rapoport, R. M.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 267, No. 5 36-5, 1994.

Research output: Contribution to journalArticle

@article{d4889ea3a79442e08636091f21fb5a36,
title = "Modulation of phorbol ester-induced contraction by endogenously released cyclooxygenase products in rat aorta",
abstract = "This study tests the hypothesis that prostaglandins (PGs) released in response to phorbol esters act as modulators of the phorbol ester-induced smooth muscle contraction. The rate and magnitude of the phorbol 12-myristate 13-acetate (PMA)-induced contraction of deendothelialized rat aorta were decreased by the cyclooxygenase inhibitor, indomethacin. The thromboxane (Tx) A2/PGH2 receptor antagonist, SQ-29548, also inhibited PMA-induced contraction, and the magnitude of inhibition was greater than that due to indomethacin. PMA induced the release of PGI2, PGE2, PGF(2α), and arachidonic acid, but not TxA2. The amount of PGI2 released was greater than that of PGE2 and PGF(2α). Indomethacin blocked the PMA-induced release of PG, but not of arachidonic acid. In PMA-contracted tissues, PGF(2α), PGE2, and the stable PGI2 and PGH2 analogues, carbacyclin and U-46619, respectively, induced further contraction. Pretreatment of PMA-contracted tissues with SQ-29548 partially inhibited the PGF(2α)- and PGE2-induced contractions, completely inhibited contraction to U-46619, and reversed the carbacyclin-induced contraction to relaxation. These results demonstrate that, in rat aorta, PMA induces the release of PGs that exert both contractile and relaxant effects but whose net effect is to accelerate and augment the contraction induced by PMA. The PG-induced increase in PMA contraction is mediated, in large part, through TxA2/PGH2 receptor activation. The ability of various PGs, including carbacyclin, to activate the TxA2/PGH2 receptor suggests that one or more of these PGs, in addition to, presumably, PGH2, may be responsible for the increase in PMA contraction. PGI2 is the only endogenously released PG that can account for the relaxant effect.",
keywords = "prostaglandin receptor, protein kinase C, smooth muscle, thromboxane receptor",
author = "Williams, {S. P.} and Campbell, {A. K.} and N. Roszell and Leslie Myatt and Leikauf, {G. D.} and Rapoport, {R. M.}",
year = "1994",
language = "English (US)",
volume = "267",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "5 36-5",

}

TY - JOUR

T1 - Modulation of phorbol ester-induced contraction by endogenously released cyclooxygenase products in rat aorta

AU - Williams, S. P.

AU - Campbell, A. K.

AU - Roszell, N.

AU - Myatt, Leslie

AU - Leikauf, G. D.

AU - Rapoport, R. M.

PY - 1994

Y1 - 1994

N2 - This study tests the hypothesis that prostaglandins (PGs) released in response to phorbol esters act as modulators of the phorbol ester-induced smooth muscle contraction. The rate and magnitude of the phorbol 12-myristate 13-acetate (PMA)-induced contraction of deendothelialized rat aorta were decreased by the cyclooxygenase inhibitor, indomethacin. The thromboxane (Tx) A2/PGH2 receptor antagonist, SQ-29548, also inhibited PMA-induced contraction, and the magnitude of inhibition was greater than that due to indomethacin. PMA induced the release of PGI2, PGE2, PGF(2α), and arachidonic acid, but not TxA2. The amount of PGI2 released was greater than that of PGE2 and PGF(2α). Indomethacin blocked the PMA-induced release of PG, but not of arachidonic acid. In PMA-contracted tissues, PGF(2α), PGE2, and the stable PGI2 and PGH2 analogues, carbacyclin and U-46619, respectively, induced further contraction. Pretreatment of PMA-contracted tissues with SQ-29548 partially inhibited the PGF(2α)- and PGE2-induced contractions, completely inhibited contraction to U-46619, and reversed the carbacyclin-induced contraction to relaxation. These results demonstrate that, in rat aorta, PMA induces the release of PGs that exert both contractile and relaxant effects but whose net effect is to accelerate and augment the contraction induced by PMA. The PG-induced increase in PMA contraction is mediated, in large part, through TxA2/PGH2 receptor activation. The ability of various PGs, including carbacyclin, to activate the TxA2/PGH2 receptor suggests that one or more of these PGs, in addition to, presumably, PGH2, may be responsible for the increase in PMA contraction. PGI2 is the only endogenously released PG that can account for the relaxant effect.

AB - This study tests the hypothesis that prostaglandins (PGs) released in response to phorbol esters act as modulators of the phorbol ester-induced smooth muscle contraction. The rate and magnitude of the phorbol 12-myristate 13-acetate (PMA)-induced contraction of deendothelialized rat aorta were decreased by the cyclooxygenase inhibitor, indomethacin. The thromboxane (Tx) A2/PGH2 receptor antagonist, SQ-29548, also inhibited PMA-induced contraction, and the magnitude of inhibition was greater than that due to indomethacin. PMA induced the release of PGI2, PGE2, PGF(2α), and arachidonic acid, but not TxA2. The amount of PGI2 released was greater than that of PGE2 and PGF(2α). Indomethacin blocked the PMA-induced release of PG, but not of arachidonic acid. In PMA-contracted tissues, PGF(2α), PGE2, and the stable PGI2 and PGH2 analogues, carbacyclin and U-46619, respectively, induced further contraction. Pretreatment of PMA-contracted tissues with SQ-29548 partially inhibited the PGF(2α)- and PGE2-induced contractions, completely inhibited contraction to U-46619, and reversed the carbacyclin-induced contraction to relaxation. These results demonstrate that, in rat aorta, PMA induces the release of PGs that exert both contractile and relaxant effects but whose net effect is to accelerate and augment the contraction induced by PMA. The PG-induced increase in PMA contraction is mediated, in large part, through TxA2/PGH2 receptor activation. The ability of various PGs, including carbacyclin, to activate the TxA2/PGH2 receptor suggests that one or more of these PGs, in addition to, presumably, PGH2, may be responsible for the increase in PMA contraction. PGI2 is the only endogenously released PG that can account for the relaxant effect.

KW - prostaglandin receptor

KW - protein kinase C

KW - smooth muscle

KW - thromboxane receptor

UR - http://www.scopus.com/inward/record.url?scp=0027985579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027985579&partnerID=8YFLogxK

M3 - Article

C2 - 7977796

AN - SCOPUS:0027985579

VL - 267

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 5 36-5

ER -